BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+11.62%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.17B
AUM Growth
+$1.17B
(+16%)
Cap. Flow
+$78.7M
Cap. Flow
% of AUM
6.71%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
149
New
25
Increased
54
Reduced
51
Closed
11
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$12.2M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$12.1M |
| 3 |
Cigna
CI
|
$11.7M |
| 4 |
Viatris
VTRS
|
$9.7M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$8.05M |
Top Sells
| 1 |
Incyte
INCY
|
$11.8M |
| 2 |
UnitedHealth
UNH
|
$11.3M |
| 3 |
Align Technology
ALGN
|
$10.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$9.27M |
| 5 |
Integra LifeSciences
IART
|
$8.56M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Industrials | 0.76% |
| 3 | Technology | 0.15% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Idexx Laboratories
IDXX
$50.7B
| $1.53M | 0.13% |
+7,000
| New | +$1.53M |
|
102
Masimo
MASI
$7.43B
| $1.45M | 0.12% |
14,800
-2,200
| -13% | -$215K |
|
|
CLLS
103
Cellectis
CLLS
$260M
| $1.43M | 0.12% |
50,600
-1,500
| -3% | -$42.4K |
|
|
OXFD
104
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.43M | 0.12% |
+110,661
| New | +$1.43M |
|
|
ITCI
105
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.41M | 0.12% |
79,900
-11,100
| -12% | -$196K |
|
106
Dynavax Technologies
DVAX
$1.19B
| $1.4M | 0.12% |
91,800
-2,700
| -3% | -$41.2K |
|
|
ARNA
107
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.37M | 0.12% |
+31,417
| New | +$1.37M |
|
108
Alkermes
ALKS
$4.95B
| $1.34M | 0.11% |
32,650
-18,250
| -36% | -$751K |
|
109
Neuronetics
STIM
$216M
| $1.32M | 0.11% |
+50,000
| New | +$1.32M |
|
|
AET
110
DELISTED
Aetna Inc
AET
| $1.3M | 0.11% |
7,100
-1,900
| -21% | -$349K |
|
|
MRTX
111
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.26M | 0.11% |
+25,500
| New | +$1.26M |
|
|
SYNH
112
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.25M | 0.11% |
+26,656
| New | +$1.25M |
|
113
Amneal Pharmaceuticals
AMRX
$3B
| $1.23M | 0.1% |
+75,000
| New | +$1.23M |
|
|
CSLT
114
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.22M | 0.1% |
+287,340
| New | +$1.22M |
|
|
FMI
115
DELISTED
Foundation Medicine, Inc.
FMI
| $1.14M | 0.1% |
+8,357
| New | +$1.14M |
|
|
TSRO
116
DELISTED
TESARO, Inc.
TSRO
| $1.12M | 0.1% |
25,250
-119,552
| -83% | -$5.32M |
|
117
Inogen
INGN
$213M
| $1.12M | 0.1% |
+6,011
| New | +$1.12M |
|
|
COTV
118
DELISTED
Cotiviti Holdings, Inc.
COTV
| $1.09M | 0.09% |
24,774
+3,066
| +14% | +$135K |
|
119
Pfizer
PFE
$141B
| $1.06M | 0.09% |
30,777
| – | – |
|
|
GWPH
120
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1M | 0.09% |
7,179
+2,304
| +47% | +$322K |
|
|
ENDP
121
DELISTED
Endo International plc
ENDP
| $934K | 0.08% |
99,092
+36,892
| +59% | +$348K |
|
122
Cardinal Health
CAH
$36B
| $879K | 0.07% |
18,000
-2,000
| -10% | -$97.7K |
|
123
Veeva Systems
VEEV
$44.4B
| $791K | 0.07% |
+10,296
| New | +$791K |
|
|
CLVS
124
DELISTED
Clovis Oncology, Inc.
CLVS
| $784K | 0.07% |
17,250
-500
| -3% | -$22.7K |
|
125
uniQure
QURE
$954M
| $764K | 0.07% |
+20,200
| New | +$764K |
|